The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cardiac Safety Assessment Services Market Research Report 2024

Global Cardiac Safety Assessment Services Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1723494

No of Pages : 115

Synopsis
Cardiac safety assessment is an important, animal or animal tissue-based experimental procedure that must be considered before entering into clinical trials. In the past few years, some drugs that have been put into clinical use have had to be withdrawn from the market or their approval has been delayed because of their potential cardiotoxicity or causing severe cardiac arrhythmias.
Global Cardiac Safety Assessment Services market is projected to reach US$ 1225 million in 2029, increasing from US$ 621 million in 2022, with the CAGR of 10.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiac Safety Assessment Services market research.
Drug-induced cardiotoxicity is one of the main reasons for new drugs to be discontinued or removed from the market. Therefore, cardiac safety assessment is a mandatory experimental procedure for various new drugs before entering clinical trials. At present, "hERG assay (hERG Assay)" (hERG assay is to evaluate the inhibitory effect of drugs on hERc current in stable expression cell lines) is considered to be the existing gold standard for preclinical cardiac safety assessment, and it is also the necessary information for new drug approval required by FDA.
Pharmaceutical companies invest in R&D to deliver high-quality and innovative products to the market, and current trends show that top pharmaceutical companies are increasing R&D efficiency through substantial R&D investments to achieve long-term ROI and through collaborative R&D efforts, which will help increase demand for preclinical and clinical services, including cardiac safety assessments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardiac Safety Assessment Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Laboratory Corporation of America Holdings
Metrion
Clario
Banook Group
Iqvia
Celerion
Certara
Biotrial
Medpace
Physiostim
Richmond Pharmacology
Ncardia
Pharmaceutical Product Development Llc.
Reaction Biology
Eurofins Discovery
Altasciences
NEXEL
charles river
Scottish Institute of Electrophysiology
杭州荣创生物科技有限公司
Segment by Type
Qube
Qpatch
Patchliner Automated Electrophysiology
Patch Clamp Electrophysiology
Plate-Based Impedance and Microelectrode Array Techniques
Segment by Application
Commissioned Research Institute
Pharmaceutical Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cardiac Safety Assessment Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Safety Assessment Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Qube
1.2.3 Qpatch
1.2.4 Patchliner Automated Electrophysiology
1.2.5 Patch Clamp Electrophysiology
1.2.6 Plate-Based Impedance and Microelectrode Array Techniques
1.3 Market by Application
1.3.1 Global Cardiac Safety Assessment Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Commissioned Research Institute
1.3.3 Pharmaceutical Company
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Safety Assessment Services Market Perspective (2018-2029)
2.2 Cardiac Safety Assessment Services Growth Trends by Region
2.2.1 Global Cardiac Safety Assessment Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cardiac Safety Assessment Services Historic Market Size by Region (2018-2023)
2.2.3 Cardiac Safety Assessment Services Forecasted Market Size by Region (2024-2029)
2.3 Cardiac Safety Assessment Services Market Dynamics
2.3.1 Cardiac Safety Assessment Services Industry Trends
2.3.2 Cardiac Safety Assessment Services Market Drivers
2.3.3 Cardiac Safety Assessment Services Market Challenges
2.3.4 Cardiac Safety Assessment Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Safety Assessment Services Players by Revenue
3.1.1 Global Top Cardiac Safety Assessment Services Players by Revenue (2018-2023)
3.1.2 Global Cardiac Safety Assessment Services Revenue Market Share by Players (2018-2023)
3.2 Global Cardiac Safety Assessment Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiac Safety Assessment Services Revenue
3.4 Global Cardiac Safety Assessment Services Market Concentration Ratio
3.4.1 Global Cardiac Safety Assessment Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Safety Assessment Services Revenue in 2022
3.5 Cardiac Safety Assessment Services Key Players Head office and Area Served
3.6 Key Players Cardiac Safety Assessment Services Product Solution and Service
3.7 Date of Enter into Cardiac Safety Assessment Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Safety Assessment Services Breakdown Data by Type
4.1 Global Cardiac Safety Assessment Services Historic Market Size by Type (2018-2023)
4.2 Global Cardiac Safety Assessment Services Forecasted Market Size by Type (2024-2029)
5 Cardiac Safety Assessment Services Breakdown Data by Application
5.1 Global Cardiac Safety Assessment Services Historic Market Size by Application (2018-2023)
5.2 Global Cardiac Safety Assessment Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cardiac Safety Assessment Services Market Size (2018-2029)
6.2 North America Cardiac Safety Assessment Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cardiac Safety Assessment Services Market Size by Country (2018-2023)
6.4 North America Cardiac Safety Assessment Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Safety Assessment Services Market Size (2018-2029)
7.2 Europe Cardiac Safety Assessment Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cardiac Safety Assessment Services Market Size by Country (2018-2023)
7.4 Europe Cardiac Safety Assessment Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Safety Assessment Services Market Size (2018-2029)
8.2 Asia-Pacific Cardiac Safety Assessment Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cardiac Safety Assessment Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Cardiac Safety Assessment Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Safety Assessment Services Market Size (2018-2029)
9.2 Latin America Cardiac Safety Assessment Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cardiac Safety Assessment Services Market Size by Country (2018-2023)
9.4 Latin America Cardiac Safety Assessment Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Safety Assessment Services Market Size (2018-2029)
10.2 Middle East & Africa Cardiac Safety Assessment Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cardiac Safety Assessment Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Cardiac Safety Assessment Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Laboratory Corporation of America Holdings
11.1.1 Laboratory Corporation of America Holdings Company Detail
11.1.2 Laboratory Corporation of America Holdings Business Overview
11.1.3 Laboratory Corporation of America Holdings Cardiac Safety Assessment Services Introduction
11.1.4 Laboratory Corporation of America Holdings Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.1.5 Laboratory Corporation of America Holdings Recent Development
11.2 Metrion
11.2.1 Metrion Company Detail
11.2.2 Metrion Business Overview
11.2.3 Metrion Cardiac Safety Assessment Services Introduction
11.2.4 Metrion Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.2.5 Metrion Recent Development
11.3 Clario
11.3.1 Clario Company Detail
11.3.2 Clario Business Overview
11.3.3 Clario Cardiac Safety Assessment Services Introduction
11.3.4 Clario Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.3.5 Clario Recent Development
11.4 Banook Group
11.4.1 Banook Group Company Detail
11.4.2 Banook Group Business Overview
11.4.3 Banook Group Cardiac Safety Assessment Services Introduction
11.4.4 Banook Group Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.4.5 Banook Group Recent Development
11.5 Iqvia
11.5.1 Iqvia Company Detail
11.5.2 Iqvia Business Overview
11.5.3 Iqvia Cardiac Safety Assessment Services Introduction
11.5.4 Iqvia Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.5.5 Iqvia Recent Development
11.6 Celerion
11.6.1 Celerion Company Detail
11.6.2 Celerion Business Overview
11.6.3 Celerion Cardiac Safety Assessment Services Introduction
11.6.4 Celerion Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.6.5 Celerion Recent Development
11.7 Certara
11.7.1 Certara Company Detail
11.7.2 Certara Business Overview
11.7.3 Certara Cardiac Safety Assessment Services Introduction
11.7.4 Certara Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.7.5 Certara Recent Development
11.8 Biotrial
11.8.1 Biotrial Company Detail
11.8.2 Biotrial Business Overview
11.8.3 Biotrial Cardiac Safety Assessment Services Introduction
11.8.4 Biotrial Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.8.5 Biotrial Recent Development
11.9 Medpace
11.9.1 Medpace Company Detail
11.9.2 Medpace Business Overview
11.9.3 Medpace Cardiac Safety Assessment Services Introduction
11.9.4 Medpace Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.9.5 Medpace Recent Development
11.10 Physiostim
11.10.1 Physiostim Company Detail
11.10.2 Physiostim Business Overview
11.10.3 Physiostim Cardiac Safety Assessment Services Introduction
11.10.4 Physiostim Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.10.5 Physiostim Recent Development
11.11 Richmond Pharmacology
11.11.1 Richmond Pharmacology Company Detail
11.11.2 Richmond Pharmacology Business Overview
11.11.3 Richmond Pharmacology Cardiac Safety Assessment Services Introduction
11.11.4 Richmond Pharmacology Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.11.5 Richmond Pharmacology Recent Development
11.12 Ncardia
11.12.1 Ncardia Company Detail
11.12.2 Ncardia Business Overview
11.12.3 Ncardia Cardiac Safety Assessment Services Introduction
11.12.4 Ncardia Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.12.5 Ncardia Recent Development
11.13 Pharmaceutical Product Development Llc.
11.13.1 Pharmaceutical Product Development Llc. Company Detail
11.13.2 Pharmaceutical Product Development Llc. Business Overview
11.13.3 Pharmaceutical Product Development Llc. Cardiac Safety Assessment Services Introduction
11.13.4 Pharmaceutical Product Development Llc. Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.13.5 Pharmaceutical Product Development Llc. Recent Development
11.14 Reaction Biology
11.14.1 Reaction Biology Company Detail
11.14.2 Reaction Biology Business Overview
11.14.3 Reaction Biology Cardiac Safety Assessment Services Introduction
11.14.4 Reaction Biology Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.14.5 Reaction Biology Recent Development
11.15 Eurofins Discovery
11.15.1 Eurofins Discovery Company Detail
11.15.2 Eurofins Discovery Business Overview
11.15.3 Eurofins Discovery Cardiac Safety Assessment Services Introduction
11.15.4 Eurofins Discovery Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.15.5 Eurofins Discovery Recent Development
11.16 Altasciences
11.16.1 Altasciences Company Detail
11.16.2 Altasciences Business Overview
11.16.3 Altasciences Cardiac Safety Assessment Services Introduction
11.16.4 Altasciences Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.16.5 Altasciences Recent Development
11.17 NEXEL
11.17.1 NEXEL Company Detail
11.17.2 NEXEL Business Overview
11.17.3 NEXEL Cardiac Safety Assessment Services Introduction
11.17.4 NEXEL Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.17.5 NEXEL Recent Development
11.18 charles river
11.18.1 charles river Company Detail
11.18.2 charles river Business Overview
11.18.3 charles river Cardiac Safety Assessment Services Introduction
11.18.4 charles river Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.18.5 charles river Recent Development
11.19 Scottish Institute of Electrophysiology
11.19.1 Scottish Institute of Electrophysiology Company Detail
11.19.2 Scottish Institute of Electrophysiology Business Overview
11.19.3 Scottish Institute of Electrophysiology Cardiac Safety Assessment Services Introduction
11.19.4 Scottish Institute of Electrophysiology Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.19.5 Scottish Institute of Electrophysiology Recent Development
11.20 杭州荣创生物科技有限公司
11.20.1 杭州荣创生物科技有限公司 Company Detail
11.20.2 杭州荣创生物科技有限公司 Business Overview
11.20.3 杭州荣创生物科技有限公司 Cardiac Safety Assessment Services Introduction
11.20.4 杭州荣创生物科技有限公司 Revenue in Cardiac Safety Assessment Services Business (2018-2023)
11.20.5 杭州荣创生物科技有限公司 Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’